{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:57:19Z","timestamp":1791665839979,"version":"4.3.4"},"reference-count":133,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Alcohol-associated liver disease (ALD) is a leading cause of liver disease worldwide, caused by hazardous alcohol use. Many patients with ALD also have alcohol use disorder (AUD), a chronic mental health condition characterized by a cluster of behavioral, cognitive, and physiological symptoms that indicate continued alcohol use despite significant alcohol-related problems. Comprehensive care of ALD often requires treatment of AUD, and evidence has demonstrated that treating the latter improves patient outcomes. However, only a minority of patients with AUD\/ALD receive treatment. Integrative care models where hepatologists work alongside AUD specialists have been developed. These partnerships have been associated with improved outcomes, including decreased rates of return to alcohol use, decreased healthcare utilization, and even improved mortality. We review the epidemiology, diagnosis, and treatment of AUD and ALD, examples of successful integrated care models, and outcomes. We also discuss knowledge gaps and areas where future research is needed, including the role of integrated care in the peri-transplantation period for ALD, harm reduction approaches, and the need for efforts to support collaboration for integrative care. In conclusion, the dual pathologies of AUD and ALD necessitate multidisciplinary care, and integrated care models have been shown to be both feasible and effective.<\/jats:p>","DOI":"10.1055\/a-2717-3496","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:14:04Z","timestamp":1761696844000},"page":"517-530","source":"Crossref","is-referenced-by-count":6,"title":["Integrated Alcohol Use Disorder and Liver Disease Management"],"prefix":"10.1055","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-9519","authenticated-orcid":false,"given":"Hanna","family":"Blaney","sequence":"additional","affiliation":[{"name":"Medstar Transplant Hepatology Institute, MedStar Georgetown University Hospital, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-8750","authenticated-orcid":false,"given":"Adelina","family":"Horhat","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Paris-Est Cr\u00e9teil University, H\u00f4pital Henri-Mondor, Assistance Publique H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmalik","family":"Saleem","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Winder","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, Henry Ford Health, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7364-5035","authenticated-orcid":false,"given":"Jessica","family":"Mellinger","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan P.","family":"Arab","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia"},{"name":"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"H Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/lt.500030314","article-title":"Predictive factors for alcoholic relapse in the selection of alcohol-dependent persons for hepatic transplant","volume":"3","author":"T P Beresford","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1005729","DOI":"10.3389\/fgstr.2022.1005729","article-title":"Sex-specific association between alcohol consumption and liver cirrhosis: an updated systematic review and meta-analysis","volume":"1","author":"L Llamosas-Falc\u00f3n","year":"2022","journal-title":"Front Gastroenterol (Lausanne)"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis","volume":"114","author":"M Roerecke","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"09","key":"ref5","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.cgh.2022.11.033","article-title":"Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis","volume":"21","author":"B S Hofer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S2468-1253(24)00232-2","article-title":"Global differences in the management of alcohol-associated hepatitis","volume":"9","author":"H Blaney","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"09","key":"ref7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/apt.17948","article-title":"Review article: current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis","volume":"59","author":"C Ramirez-Cadiz","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41572-022-00406-1","article-title":"Hazardous drinking and alcohol use disorders","volume":"8","author":"J MacKillop","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","article-title":"Alcohol use disorders","volume":"394","author":"A F Carvalho","year":"2019","journal-title":"Lancet"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.15613","article-title":"Efficacy of brief intervention for harmful and hazardous alcohol use: a systematic review and meta-analysis of studies from low middle-income countries","volume":"117","author":"A Ghosh","year":"2022","journal-title":"Addiction"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/add.12960","article-title":"A comparison of the efficacy of brief interventions to reduce hazardous and harmful alcohol consumption between European and non-European countries: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"C Elzerbi","year":"2015","journal-title":"Addiction"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"e208279","DOI":"10.1001\/jamanetworkopen.2020.8279","article-title":"Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis","volume":"3","author":"L A Ray","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: Alcohol-associated liver disease","volume":"119","author":"L L Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"A Louvet","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/lt.23762","article-title":"Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis","volume":"19","author":"J P Rice","year":"2013","journal-title":"Liver Transpl"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"100832","DOI":"10.1016\/j.jhepr.2023.100832","article-title":"Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse","volume":"5","author":"J Daniel","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/lt.20934","article-title":"Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease","volume":"13","author":"R Pfitzmann","year":"2007","journal-title":"Liver Transpl"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis","volume":"71","author":"S Rogal","year":"2020","journal-title":"Hepatology"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/acer.15443","article-title":"Enhancing alcohol use disorder care in alcohol-associated liver disease: patient perspectives and systemic barriers","volume":"48","author":"H Blaney","year":"2024","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.cgh.2020.10.026","article-title":"Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the study of liver diseases alcohol-associated liver disease special interest group","volume":"19","author":"G Y Im","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/hep.30358","article-title":"Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease","volume":"70","author":"F Caputo","year":"2019","journal-title":"Hepatology"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/hep.31235","article-title":"Integrated treatment of alcohol use disorder in patients with alcohol-associated liver disease: an evolving story","volume":"71","author":"M R Lucey","year":"2020","journal-title":"Hepatology"},{"key":"ref23","volume-title":"Global Status Report on Alcohol and Health and Treatment of Substance Use Disorders","author":"World Health Organization","year":"2024"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0140-6736(18)32744-2","article-title":"Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study","volume":"393","author":"J Manthey","year":"2019","journal-title":"Lancet"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12889-023-15749-x","article-title":"Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis","volume":"23","author":"X Niu","year":"2023","journal-title":"BMC Public Health"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"e0133","DOI":"10.1097\/HC9.0000000000000133","article-title":"Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis","volume":"7","author":"S Amonker","year":"2023","journal-title":"Hepatol Commun"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"08","key":"ref30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"G Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"09","key":"ref31","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.cgh.2022.03.017","article-title":"Alcohol-associated liver disease mortality increased from 2017 to 2020 and accelerated during the COVID-19 pandemic","volume":"20","author":"S Deutsch-Link","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/TP.0000000000004701","article-title":"Racial and ethnic disparities in liver transplantation for alcohol-associated liver diseases in the United States","volume":"108","author":"T G Cotter","year":"2024","journal-title":"Transplantation"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/apt.16461","article-title":"Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics","volume":"54","author":"A K Singal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/a-2000-6680","article-title":"The changing epidemiology of alcohol-associated liver disease: gender, race, and risk factors","volume":"43","author":"A Anouti","year":"2023","journal-title":"Semin Liver Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000905","article-title":"Sex and gender in alcohol use disorder and alcohol-associated liver disease in the United States: a narrative review","author":"L E Carlini","year":"2024","journal-title":"Hepatology"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.14309\/ajg.0000000000002642","article-title":"From shadows to spotlight: exploring the escalating burden of alcohol-associated liver disease and alcohol use disorder in young women","volume":"119","author":"P Danpanichkul","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"100172","DOI":"10.1016\/j.lanepe.2021.100172","article-title":"Socioeconomic inequalities in the incidence of alcohol-related liver disease: a nationwide Danish study","volume":"8","author":"G Askgaard","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"06","key":"ref38","first-page":"e0160","article-title":"Disproportionate increases in alcohol-associated hepatitis incidence in women and individuals of low socioeconomic status: a population-based study using the Rochester epidemiology project database","volume":"7","author":"J C Ahn","year":"2023","journal-title":"Hepatol Commun"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12876-019-1050-9","article-title":"Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis","volume":"19","author":"L Chuncharunee","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/acer.13567","article-title":"Concomitant psychiatric and nonalcohol-related substance use disorders among hospitalized patients with alcoholic liver disease in the United States","volume":"42","author":"R Jinjuvadia","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2005.03.009","article-title":"Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"80","author":"F S Stinson","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/lt.20688","article-title":"Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease","volume":"12","author":"A DiMartini","year":"2006","journal-title":"Liver Transpl"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/alcalc\/agx100","article-title":"Post-transplant outcomes of persons receiving a liver graft for alcoholic liver disease","volume":"53","author":"S Rogal","year":"2018","journal-title":"Alcohol Alcohol"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"e0132","DOI":"10.1097\/HC9.0000000000000132","article-title":"Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis","volume":"7","author":"M Schroeder","year":"2023","journal-title":"Hepatol Commun"},{"issue":"08","key":"ref45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","author":"J Dumortier","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.14309\/ajg.0000000000001007","article-title":"Excess mortality after liver transplantation in young women with alcohol-associated liver disease","volume":"116","author":"B P Lee","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaclp.2023.11.683","article-title":"Clinical utility and impact of phosphatidylethanol testing in liver transplantation evaluations","volume":"65","author":"D C Fipps","year":"2024","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"09","key":"ref48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1360-0443.1988.tb00526.x","article-title":"Validity of self-reported alcohol use: a literature review and assessment","volume":"83","author":"L T Midanik","year":"1988","journal-title":"Br J Addict"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/lt.22370","article-title":"Substance use by liver transplant candidates: an anonymous urinalysis study","volume":"17","author":"I Webzell","year":"2011","journal-title":"Liver Transpl"},{"key":"ref50","volume-title":"Dietary Guidelines for Americans, 2015\u20132020 Eighth Edition","author":"Office of Disease Prevention, U. S. Department of Health","year":"2020"},{"issue":"06","key":"ref51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II","volume":"88","author":"J B Saunders","year":"1993","journal-title":"Addiction"},{"issue":"07","key":"ref53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11606-009-0928-6","article-title":"Primary care validation of a single-question alcohol screening test","volume":"24","author":"P C Smith","year":"2009","journal-title":"J Gen Intern Med"},{"key":"ref54","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2021"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"K Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"08","key":"ref56","doi-asserted-by":"crossref","first-page":"e0182162","DOI":"10.1371\/journal.pone.0182162","article-title":"Psychometric analysis of the generalized anxiety disorder scale (GAD-7) in primary care using modern item response theory","volume":"12","author":"P Jordan","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis","volume":"13","author":"G Viel","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1040605","article-title":"Histologic spectrum of alcoholic liver disease","volume":"6","author":"R N MacSween","year":"1986","journal-title":"Semin Liver Dis"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"R K Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"07","key":"ref60","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1572-0241.2006.00610.x","article-title":"Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis","volume":"101","author":"C S Lieber","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs fibrotest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"M Thiele","year":"2018","journal-title":"Gastroenterology"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-2036.2008.03831.x","article-title":"Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests","volume":"28","author":"E Nguyen-Khac","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/liv.13440","article-title":"Transient elastography alone and in combination with FibroTest for the diagnosis of hepatic fibrosis in alcoholic liver disease","volume":"37","author":"C S Voican","year":"2017","journal-title":"Liver Int"},{"issue":"10","key":"ref64","doi-asserted-by":"crossref","first-page":"101165","DOI":"10.1016\/j.jhepr.2024.101165","article-title":"Liver fibrosis screening increases alcohol abstinence","volume":"6","author":"E Avitabile","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"06","key":"ref65","doi-asserted-by":"crossref","first-page":"agae074","DOI":"10.1093\/alcalc\/agae074","article-title":"Early detection of liver disease in patients with alcohol use disorder improves long-term abstinence","volume":"59","author":"A Orgill","year":"2024","journal-title":"Alcohol Alcohol"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"e0414","DOI":"10.1097\/HC9.0000000000000414","article-title":"Hepatology consultation is associated with decreased early return to alcohol use after discharge from an inpatient alcohol use disorder treatment program","volume":"8","author":"H L Blaney","year":"2024","journal-title":"Hepatol Commun"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"570","DOI":"10.14309\/ajg.0000000000002953","article-title":"The liver cirrhosis network cohort study: cirrhosis definition, study population, and endpoints","volume":"120","author":"E B Tapper","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"R Wiesner","year":"2003","journal-title":"Gastroenterology"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"D W Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/liv.15221","article-title":"Management of alcohol-related liver disease: the French Association for the study of the liver and the French Alcohol Society clinical guidelines","volume":"42","author":"A Louvet","year":"2022","journal-title":"Liver Int"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"W C Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"05","key":"ref72","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study","volume":"75","author":"J P Arab","year":"2021","journal-title":"J Hepatol"},{"issue":"17","key":"ref73","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"M R Thursz","year":"2015","journal-title":"N Engl J Med"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/CLD.0000000000000054","article-title":"Steroid use in alcohol-associated hepatitis: a history","volume":"21","author":"H Blaney","year":"2023","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"01","key":"ref75","first-page":"1","article-title":"Behavioral dysregulations by chronic alcohol abuse. Motivational enhancement therapy and cognitive behavioral therapy outcomes","volume":"57","author":"F M Ceci","year":"2022","journal-title":"Riv Psichiatr"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.psc.2010.04.012","article-title":"Cognitive behavioral therapy for substance use disorders","volume":"33","author":"R K McHugh","year":"2010","journal-title":"Psychiatr Clin North Am"},{"issue":"06","key":"ref77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/alcalc\/agaa050","article-title":"Alcoholics Anonymous and 12-step facilitation treatments for alcohol use disorder: a distillation of a 2020 Cochrane review for clinicians and policy makers","volume":"55","author":"J F Kelly","year":"2020","journal-title":"Alcohol Alcohol"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2016.10.004","article-title":"Treatment of alcohol use disorder in patients with alcoholic liver disease","volume":"130","author":"L Leggio","year":"2017","journal-title":"Am J Med"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ADM.0000000000001421","article-title":"Drug-induced liver injury due to medications for alcohol use disorder: results from the DILIN prospective study","volume":"19","author":"H Gopalakrishna","year":"2025","journal-title":"J Addict Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/TCRM.S23184","article-title":"Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility","volume":"8","author":"K Witkiewitz","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/B978-0-444-62619-6.00030-6","article-title":"Pharmacologic treatment of alcoholism","volume":"125","author":"R F Anton","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"ref82","first-page":"36","article-title":"The COMBINE study-: an overview of the largest pharmacotherapy study to date for treating alcohol dependence","volume":"3","author":"H M Pettinati","year":"2006","journal-title":"Psychiatry (Edgmont)"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"101095","DOI":"10.1016\/j.jhepr.2024.101095","article-title":"Safety of naltrexone in patients with cirrhosis","volume":"6","author":"R Thompson","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"12","key":"ref84","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/hep4.2080","article-title":"Naltrexone for alcohol use disorder: hepatic safety in patients with and without liver disease","volume":"6","author":"D Ayyala","year":"2022","journal-title":"Hepatol Commun"},{"issue":"9603","key":"ref85","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"G Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"e2213014","DOI":"10.1001\/jamanetworkopen.2022.13014","article-title":"Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder","volume":"5","author":"A GL Vannier","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"17","key":"ref87","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"R F Anton","year":"2006","journal-title":"JAMA"},{"issue":"04","key":"ref88","doi-asserted-by":"crossref","first-page":"516","DOI":"10.15288\/jsad.2009.70.516","article-title":"Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials","volume":"70","author":"M Magill","year":"2009","journal-title":"J Stud Alcohol Drugs"},{"issue":"06","key":"ref89","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MEG.0000000000001583","article-title":"Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis","volume":"32","author":"Y Al-Azzawi","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"08","key":"ref90","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jama.1948.02900080001001","article-title":"Dietary treatment of cirrhosis of the liver; results in 124 patients observed during a 10 year period","volume":"138","author":"A J Patek Jr","year":"1948","journal-title":"J Am Med Assoc"},{"issue":"01","key":"ref91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"K P Moore","year":"2003","journal-title":"Hepatology"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00535-023-02060-0","article-title":"Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials","volume":"59","author":"T Kawaguchi","year":"2024","journal-title":"J Gastroenterol"},{"issue":"02","key":"ref93","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.22426","article-title":"Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation","volume":"18","author":"J M Prentis","year":"2012","journal-title":"Liver Transpl"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/lt.22472","article-title":"Exercise capacity and muscle strength in patients with cirrhosis","volume":"18","author":"J C Jones","year":"2012","journal-title":"Liver Transpl"},{"issue":"11","key":"ref95","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.cgh.2014.04.016","article-title":"Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis","volume":"12","author":"L Zenith","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0376-8716(02)00220-X","article-title":"Alcohol use disorders comorbid with anxiety, depression and drug use disorders","volume":"68","author":"L Burns","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"06","key":"ref97","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cld.1129","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a patient-friendly summary of the 2019 AASLD guidelines","volume":"17","author":"M Bertha","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"03","key":"ref99","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","article-title":"Alcohol-related liver disease: clinical practice guidelines by the Latin American Association for the study of the liver (ALEH)","volume":"18","author":"J P Arab","year":"2019","journal-title":"Ann Hepatol"},{"issue":"04","key":"ref100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dld.2019.12.008","article-title":"Alcohol associated liver disease 2020: a clinical practice guideline by the Italian Association for the study of the liver (AISF)","volume":"52","author":"G Addolorato","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"02","key":"ref101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"A Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"02","key":"ref102","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/ADM.0000000000001084","article-title":"Simultaneous management of alcohol use disorder and liver disease: a systematic review and meta-analysis","volume":"17","author":"M A Elfeki","year":"2023","journal-title":"J Addict Med"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"108396","DOI":"10.1016\/j.jsat.2021.108396","article-title":"Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic","volume":"130","author":"J L Mellinger","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"09","key":"ref104","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"G Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"04","key":"ref105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/flgastro-2019-101241","article-title":"Alcohol care teams: where are we now?","volume":"11","author":"K J Moriarty","year":"2019","journal-title":"Frontline Gastroenterol"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/flgastro-2012-100260","article-title":"Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions","volume":"4","author":"N R Hughes","year":"2013","journal-title":"Frontline Gastroenterol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12889-016-3350-0","article-title":"The impact of alcohol care teams on emergency secondary care use following a diagnosis of alcoholic liver disease - a national cohort study","volume":"16","author":"C Currie","year":"2016","journal-title":"BMC Public Health"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.cgh.2022.03.042","article-title":"Creation of an inpatient alcohol liver service improves early liver disease detection in patients with alcohol use disorder","volume":"21","author":"V Fomin","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"02","key":"ref109","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/acer.13944","article-title":"Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis","volume":"43","author":"J L Mellinger","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/appi.ps.202000565","article-title":"How physician workforce shortages are hampering the response to the opioid crisis","volume":"73","author":"J McNeely","year":"2022","journal-title":"Psychiatr Serv"},{"issue":"06","key":"ref111","first-page":"e4585","article-title":"The association of state-level drug and opioid overdose deaths with the capacity of behavioural health professionals in the United States","volume":"30","author":"X Han","year":"2022","journal-title":"Health Soc Care Community"},{"issue":"02","key":"ref112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ypmed.2006.02.006","article-title":"Problem drinking: rural and urban trends in America, 1995\/1997 to 2003","volume":"43","author":"J E Jackson","year":"2006","journal-title":"Prev Med"},{"issue":"05","key":"ref113","doi-asserted-by":"crossref","first-page":"e14299","DOI":"10.1111\/1475-6773.14299","article-title":"Rural-urban differences in out-of-network treatment initiation and engagement rates for substance use disorders","volume":"59","author":"E Raver","year":"2024","journal-title":"Health Serv Res"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hep.32597","article-title":"Access to technology to support telehealth in areas without specialty care for liver disease","volume":"77","author":"J B Henson","year":"2023","journal-title":"Hepatology"},{"issue":"06","key":"ref115","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/acer.14609","article-title":"A cascade of care for alcohol use disorder: using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care","volume":"45","author":"C M Mintz","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"02","key":"ref116","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/LVT.0000000000000296","article-title":"Alcohol use disorder in alcohol-associated liver disease: two sides of the same coin","volume":"30","author":"A K Singal","year":"2024","journal-title":"Liver Transpl"},{"issue":"02","key":"ref117","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2468-1253(21)00191-6","article-title":"Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models","volume":"7","author":"A F DiMartini","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"04","key":"ref118","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cld.2024.06.012","article-title":"Barriers to alcohol use disorder treatment in patients with alcohol-associated liver disease","volume":"28","author":"A H L\u00e9k\u00f3","year":"2024","journal-title":"Clin Liver Dis"},{"issue":"13","key":"ref119","doi-asserted-by":"crossref","first-page":"730","DOI":"10.12968\/bjon.2018.27.13.730","article-title":"Understanding alcohol-related liver disease patients' illness beliefs and views about their medicine","volume":"27","author":"J Presky","year":"2018","journal-title":"Br J Nurs"},{"issue":"12","key":"ref120","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/aje\/kwq304","article-title":"Stigma and treatment for alcohol disorders in the United States","volume":"172","author":"K M Keyes","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"02","key":"ref121","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2022.04.026","article-title":"The stigma of alcohol-related liver disease and its impact on healthcare","volume":"77","author":"G Schomerus","year":"2022","journal-title":"J Hepatol"},{"issue":"04","key":"ref122","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/apt.18122","article-title":"Financial hardship and cost-related nonadherence to medication in patients with liver disease in the United States","volume":"60","author":"D Kim","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"06","key":"ref123","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s10620-019-5471-7","article-title":"Charges for alcoholic cirrhosis exceed all other etiologies of cirrhosis combined: a national and state inpatient survey analysis","volume":"64","author":"A S Barritt IV","year":"2019","journal-title":"Dig Dis Sci"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2018.05.003","article-title":"Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis","volume":"91","author":"J L Mellinger","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"ref125","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/acer.15427","article-title":"Treatment engagement in comorbid alcohol use disorder and alcohol-related liver disease: a qualitative exploration of barriers and facilitators with service users","volume":"48","author":"S Hemrage","year":"2024","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-154-1-201101040-00008","article-title":"Integrating addiction medicine into graduate medical education in primary care: the time has come","volume":"154","author":"P G O'Connor","year":"2011","journal-title":"Ann Intern Med"},{"issue":"11","key":"ref127","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s11606-021-07102-y","article-title":"Training in safe opioid prescribing and treatment of opioid use disorder in internal medicine residencies: A national survey of Program Directors","volume":"37","author":"D M Windish","year":"2022","journal-title":"J Gen Intern Med"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"107738","DOI":"10.1016\/j.pec.2023.107738","article-title":"A survey of motivational interviewing training experiences among internal medicine residents","volume":"112","author":"C A Chan","year":"2023","journal-title":"Patient Educ Couns"},{"issue":"12","key":"ref129","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/lt.23747","article-title":"Substance abuse treatment and its association with relapse to alcohol use after liver transplantation","volume":"19","author":"J R Rodrigue","year":"2013","journal-title":"Liver Transpl"},{"issue":"04","key":"ref130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jceh.2022.01.010","article-title":"Integrated care of alcohol-related liver disease","volume":"12","author":"G S Winder","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"01","key":"ref131","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/S2589-7500(24)00174-2","article-title":"The new digital era in decompensated cirrhosis","volume":"7","author":"K Gananandan","year":"2025","journal-title":"Lancet Digit Health"},{"issue":"07","key":"ref132","doi-asserted-by":"crossref","first-page":"e15381","DOI":"10.1111\/ctr.15381","article-title":"A tailored virtual program for alcohol use disorder treatment among liver transplant candidates and recipients is feasible and associated with lower post-transplant relapse","volume":"38","author":"A Goswami","year":"2024","journal-title":"Clin Transplant"},{"issue":"11","key":"ref133","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.3390\/ijerph121114828","article-title":"Harm reduction as \u201ccontinuum care\u201d in alcohol abuse disorder","volume":"12","author":"I Maremmani","year":"2015","journal-title":"Int J Environ Res Public Health"},{"issue":"03","key":"ref134","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jhep.2023.11.006","article-title":"Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes","volume":"80","author":"L A D\u00edaz","year":"2024","journal-title":"J Hepatol"},{"issue":"05","key":"ref135","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/hep.32016","article-title":"Impact of public health policies on alcohol-associated liver disease in Latin America: an ecological multinational study","volume":"74","author":"L A D\u00edaz","year":"2021","journal-title":"Hepatology"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(23)00497-X","article-title":"Evaluating the impact of alcohol minimum unit pricing on deaths and hospitalisations in Scotland: a controlled interrupted time series study","volume":"401","author":"G MA Wyper","year":"2023","journal-title":"Lancet"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2717-3496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T23:48:14Z","timestamp":1764805694000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2717-3496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":133,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2717-3496","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}